亚洲 · 区域市场 · CNBC-TV18
Emcure Pharma Q2 Results: Stock jumps 7% after international expansion, domestic momentum drives growth
Emcure Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) for the quarter stood at ₹587.3 crore, a growth of 23.5% from the year-ago period, while…
在 CNBC-TV18 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.cnbctv18.com)
